Regenerative Medical Technology Group expands ISSCA AI clinical platform
Regenerative Medical Technology Group said it is expanding details of its ISSCA AI clinical intelligence platform, including a protocol-native engine, structured data assets, and a multi-line commercial model, with physicians retaining decision-maker control.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.